Founded in February 2014, Nanochap is headquartered in Zhejiang overseas high-level talent innovation park and has a research and development center in Melbourne, Australia. The company is committed to the research and development of core chips in biomedical field. It is one of the earliest enterprises engaged in the research of "high-resolution artificial retina" in China. It has more than 10 years of research and development experience. Nanochap lays out the fields of neural interface and biosensing related chips, and presides over the "13th Five-Year" national key project: R & D of high-resolution artificial retina. The company is committed to the research and development and sales of ultra-high density neural interface chips, biosensing chips and related medical device products to fill the gaps in China's related fields and rank among the world's cutting-edge.